<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00872339</url>
  </required_header>
  <id_info>
    <org_study_id>639</org_study_id>
    <secondary_id>U01HL065238</secondary_id>
    <nct_id>NCT00872339</nct_id>
  </id_info>
  <brief_title>Assessment of Pain in People With Thalassemia</brief_title>
  <acronym>Pain</acronym>
  <official_title>Assessment of Pain in People With Thalassemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New England Research Institutes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>New England Research Institutes</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thalassemia is an inherited blood disorder that can result in mild to severe anemia. People
      with thalassemia often experience pain, but the exact sources and prevalence of pain remain
      unknown. This study will examine the prevalence and severity of pain in people with
      thalassemia who are treated with regular blood transfusions and people with thalassemia who
      are not treated with regular blood transfusions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thalassemia is an inherited blood disorder in which the body makes an abnormal form of
      hemoglobin—the protein in red blood cells that carries oxygen. People with thalassemia often
      experience fatigue, shortness of breath, and pain. Recent medical advances in treating people
      with thalassemia who receive regular blood transfusions—a standard procedure that refreshes
      the healthy red blood supply—have resulted in increased life spans for these people. However,
      with the extended life spans have come additional issues, including pain. There have been no
      previous research studies that have examined pain levels in people with thalassemia, and as a
      result, the sources and prevalence of pain remain unknown. The purpose of this study is to
      assess the prevalence and severity of pain, common pain sites, and the impact of pain on
      functioning and well-being in people with thalassemia who receive regular blood transfusions
      and people with thalassemia who do not receive regular blood transfusions.

      This study will enroll people with transfusion-dependant thalassemia and people with
      non-transfusion-dependant thalassemia. At a baseline study visit, participants will complete
      a demographic questionnaire and a pain assessment questionnaire. At Months 3, 6, and 9, study
      researchers will telephone participants to go over the same pain assessment questionnaire
      again.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of Pain</measure>
    <time_frame>Measured at Month 9</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Common Sites of Pain</measure>
    <time_frame>Measured at Month 9</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Occurrence by Age</measure>
    <time_frame>Measured at Month 9</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of Pain on Functioning and Well-being</measure>
    <time_frame>Measured at Month 9</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">252</enrollment>
  <condition>Thalassemia</condition>
  <arm_group>
    <arm_group_label>transfusion-dependant</arm_group_label>
    <description>People with transfusion-dependant thalassemia who received at least 8 transfusions in the past year.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-transfusion-dependant</arm_group_label>
    <description>People with non-transfusion-dependant thalassemia who received no transfusions in the past year.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intermittently transfused</arm_group_label>
    <description>Intermittently transfused patients- individuals who received at least one but fewer than eight transfusions in the last year</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Thalassemia patients who receive regular blood transfusions and those who do not receive
        regular blood transfusions.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Thalassemia, as documented by clinical diagnosis, including the following:

               1. B-thalassemia (intermedia or major)

               2. Hgb H disease

               3. Hgb H with non-deletional mutations (e.g., Hgb H Constant Spring)

               4. E-B-thalassemia

               5. Homozygous alpha thalassemia

               6. Other thalassemic conditions not explicitly excluded

               7. Thalassemia intermedia due to heterozygous B mutation with an alpha excess

          -  Participants can be of any race, ethnicity, and either gender.

        Exclusion Criteria:

          -  Thalassemia trait (i.e., single recessive B gene mutation, 2 gene alpha mutation) and
             thalassemia Hgb S, C, or D compound heterozygotes

          -  Unwillingness or inability to complete the Brief Pain Inventory (BPI) on a quarterly
             basis

          -  Has had a successful bone marrow transplant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeanne Boudreeaux, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Healthcare of Atlanta</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ellis Neufeld, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Children’s Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alexis Thompson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Memorial Hospital of Chicago</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brigitta Mueller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor College of Medicine at Houston</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dru Foote, RN, NP</last_name>
    <role>Study Chair</role>
    <affiliation>Children's Hospital and Research Institute of Oakland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patricia Giardina, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Weill Medical College of Cornell</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Janet Kwiatkowski, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Philadelphia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nancy Olivieri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Toronto General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital and Research Institute at Oakland</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Healthcare of Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Memorial Hospital of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Weill Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toronto General Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Haines D, Martin M, Carson S, Oliveros O, Green S, Coates T, Eile J, Schilling L, Dinu B, Mendoza T, Gerstenberger E, Trachtenberg F, Vichinsky E; Thalassemia Clinical Research Network. Pain in thalassaemia: the effects of age on pain frequency and severity. Br J Haematol. 2013 Mar;160(5):680-7. doi: 10.1111/bjh.12177. Epub 2012 Dec 30.</citation>
    <PMID>23278768</PMID>
  </results_reference>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2009</study_first_submitted>
  <study_first_submitted_qc>March 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2009</study_first_posted>
  <results_first_submitted>January 2, 2014</results_first_submitted>
  <results_first_submitted_qc>May 27, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 5, 2014</results_first_posted>
  <last_update_submitted>May 27, 2014</last_update_submitted>
  <last_update_submitted_qc>May 27, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 5, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Transfusion-Dependent Thalassemia</keyword>
  <keyword>Non-Transfusion-Dependent Thalassemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thalassemia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Transfusion-dependant</title>
          <description>People with transfusion-dependant thalassemia.</description>
        </group>
        <group group_id="P2">
          <title>Intermittently Transfused</title>
          <description>Intermittently transfused patients- individuals who received fewer than eight transfusions in the last year</description>
        </group>
        <group group_id="P3">
          <title>Non-transfusion-dependant</title>
          <description>People with non-transfusion-dependant thalassemia.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="201"/>
                <participants group_id="P2" count="14"/>
                <participants group_id="P3" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="201"/>
                <participants group_id="P2" count="14"/>
                <participants group_id="P3" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Transfusion-dependant</title>
          <description>People with transfusion-dependant thalassemia.</description>
        </group>
        <group group_id="B2">
          <title>Intermittently Transfused</title>
          <description>Intermittently transfused patients- individuals who received fewer than eight transfusions in the last year</description>
        </group>
        <group group_id="B3">
          <title>Non-transfusion-dependant</title>
          <description>People with non-transfusion-dependant thalassemia.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="201"/>
            <count group_id="B2" value="14"/>
            <count group_id="B3" value="37"/>
            <count group_id="B4" value="252"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.2" spread="10.4"/>
                    <measurement group_id="B2" value="35.8" spread="14.4"/>
                    <measurement group_id="B3" value="29.5" spread="16.2"/>
                    <measurement group_id="B4" value="28.8" spread="11.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="117"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="84"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Prevalence of Pain</title>
        <time_frame>Measured at Month 9</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Transfusion-dependant</title>
            <description>People with transfusion-dependant thalassemia.</description>
          </group>
          <group group_id="O2">
            <title>Intermittently Transfused</title>
            <description>Intermittently transfused patients- individuals who received fewer than eight transfusions in the last year</description>
          </group>
          <group group_id="O3">
            <title>Non-transfusion-dependant</title>
            <description>People with non-transfusion-dependant thalassemia.</description>
          </group>
        </group_list>
        <measure>
          <title>Prevalence of Pain</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="201"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.45</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Common Sites of Pain</title>
        <time_frame>Measured at Month 9</time_frame>
        <group_list>
          <group group_id="O1">
            <title>All Subjects Combined</title>
            <description>Subjects with pain in the last 7 days were combined into one group.</description>
          </group>
        </group_list>
        <measure>
          <title>Common Sites of Pain</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="93"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Lower back</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Either leg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Head</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Midback</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Either hip</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Upper back</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Either arm</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abdomen</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chest</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Occurrence by Age</title>
        <time_frame>Measured at Month 9</time_frame>
        <group_list>
          <group group_id="O1">
            <title>All Subjects Combined</title>
            <description>Subjects were combined into one group.</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Occurrence by Age</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="252"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12-17 yo (n=50)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18-24 (n=56)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>25-34 (n=61)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>35-44 (n=61)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>45-71 (n=24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.001</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Impact of Pain on Functioning and Well-being</title>
        <time_frame>Measured at Month 9</time_frame>
        <group_list>
          <group group_id="O1">
            <title>All Subjects Combined</title>
            <description>Subjects with pain in the last 7 days were combined into one group.</description>
          </group>
        </group_list>
        <measure>
          <title>Impact of Pain on Functioning and Well-being</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="93"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Mood</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal work</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>General activities</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sleep</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Walking</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Enjoyment of life</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Interpersonal relations</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were not collected for this study.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Adverse Events Were Not Collected</title>
          <description>Adverse events were not collected for this study.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Felicia Trachtenberg</name_or_title>
      <organization>New England Research Institutes</organization>
      <phone>6179723120</phone>
      <email>ftrachtenberg@neriscience.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

